Workflow
Invezz
icon
Search documents
Novo Nordisk shares plunge as oral semaglutide Alzheimer's trial fails to show clinical benefit
Invezz· 2025-11-24 12:57
Shares of Novo Nordisk fell sharply on Monday after the company announced that a high-profile trial testing whether its oral semaglutide medicine could slow the progression of Alzheimer's disease had ... ...
BHP drops $60B Anglo American bid to focus on organic growth
Invezz· 2025-11-24 11:25
On Monday, investors urged BHP to drop its pursuit of Anglo American and instead focus on its established growth strategy. This advice comes after the Australian firm's recent, last-ditch effort to a... ...
Bayer stock jump 9% as stroke drug trial revives confidence in pipeline
Invezz· 2025-11-24 10:01
Core Viewpoint - Bayer shares experienced a significant increase following positive late-stage clinical trial results for its experimental cardiovascular drug asundexian, marking a rare positive development for its pharmaceutical division, which has faced challenges and rising litigation costs [1] Group 1 - Bayer's stock rose over 9%, reaching €30.30, the highest level in over a week [1]
Top FTSE 100 Index shares to watch: EasyJet, Anglo American, Kingfisher
Invezz· 2025-11-24 08:09
Core Insights - The FTSE 100 Index has experienced significant pressure recently due to heightened volatility in global stocks [1] - The index fell to a low of £9,540, representing a decline of over 4% from its peak this year [1] Market Performance - The FTSE 100 Index's recent low indicates a challenging market environment for investors [1] - The decline reflects broader trends in global stock markets, suggesting a potential shift in investor sentiment [1]
DBS revises Malaysia bank stake plan as regulatory limits shape strategy
Invezz· 2025-11-24 07:17
Singapore's DBS Group has adjusted its expansion move in Malaysia by submitting a fresh request to acquire a smaller stake in Alliance Bank Malaysia. The filing, made after the first application was n... ...
Here's why the Rolls-Royce share price has moved into a correction
Invezz· 2025-11-24 07:05
Core Viewpoint - Rolls-Royce share price has experienced a significant pullback, moving from a year-to-date high of 1,194p in September to the current price of 1,038p, indicating a correction of over 13% [1] Price Movement - The share price decline represents a correction phase for Rolls-Royce, highlighting volatility in the stock market [1] - The current price of 1,038p reflects a notable decrease from the previous high, suggesting potential investor concerns or market adjustments [1]
Alibaba deepens AI push as Qwen app surges after major relaunch
Invezz· 2025-11-24 06:55
Core Insights - Alibaba's consumer AI strategy has gained significant momentum with the relaunch of its mobile apps under the Qwen brand, achieving over 10 million downloads within a week [1] Group 1 - The relaunch of mobile apps under the Qwen brand indicates a strategic shift towards enhancing consumer AI offerings [1] - Achieving more than 10 million downloads in just one week demonstrates strong market interest and potential user engagement [1]
TotalEnergies plans to sell up to 6% stake in Adani Green Energy: report
Invezz· 2025-11-24 06:48
TotalEnergies is preparing to divest up to a 6% stake in Adani Green Energy Ltd (AGEL), reported The Economic Times, citing people familiar with the matter. The move marks a significant development in... ...
Here's why Tata Consultancy Services share price is ripe for a comeback
Invezz· 2025-11-24 05:39
Core Insights - Tata Consultancy Services (TCS) share price has shown a recovery trend in recent weeks, rebounding over 10% from a low of 2,856 in October to the current price of 3,155 [1] Company Summary - The share price of TCS reached a low of 2,856 in October, indicating a significant downturn prior to the recent recovery [1] - The current share price of TCS stands at 3,155, reflecting a rebound of more than 10% from its previous low [1]
JPMorgan names top European bank stocks to own heading into 2026
Invezz· 2025-11-23 11:00
Core Viewpoint - JPMorgan's senior analyst Kian Abouhossein has identified preferred European bank stocks as investors prepare for 2026 amidst macroeconomic uncertainty and varied M&A activity in the sector [1] Group 1: Analyst Insights - The analysis highlights the importance of selecting bank stocks that can withstand economic fluctuations and capitalize on potential growth opportunities [1] - Abouhossein's recommendations are based on a thorough evaluation of the banks' fundamentals and market positioning [1] Group 2: Market Context - The current macroeconomic environment presents challenges, including inflationary pressures and interest rate changes, which could impact bank performance [1] - M&A activity in the banking sector remains inconsistent, influencing investor sentiment and stock valuations [1]